SCHEMBL19628162

SCHEMBL19628162

c1ccc2cc(-c3cc4cccc5c6c7ccc(-c8cccc9ccccc89)cc7sc6c6cccc3c6c45)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 9/20 0.36
S1PR4 O95977 7/20 0.36
PIM1 P11309 2/20 0.35
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
ALOX5 P09917 1/20 0.34
LIMK1 P53667 2/20 0.34
GSTP1 P09211 1/20 0.34
CYP1A2 P05177 2/20 0.33
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628164 0.97 CA12 (0.37) S1PR5S1PR4PIM1MCL1ACMSD
SCHEMBL19628161 0.94 GSTP1 (0.36) S1PR5S1PR4ALOX5LIMK1GSTP1
SCHEMBL19628151 0.93 CYP1A2 (0.39) S1PR5S1PR4ALOX5LIMK1GSTP1
SCHEMBL19628167 0.91 GPR84 (0.35) S1PR5S1PR4ALOX5LIMK1GSTP1
SCHEMBL19628158 0.91 LIMK1 (0.38) S1PR5S1PR4MCL1LIMK1GSTP1
SCHEMBL19628153 0.89 ALOX5 (0.41) S1PR5S1PR4ALOX5GSTP1CYP1A2
SCHEMBL19628185 0.86 ALOX5 (0.41) S1PR5S1PR4MCL1ACMSDALOX5
SCHEMBL19628166 0.86 S1PR5 (0.39) S1PR5S1PR4PIM1ALOX5GSTP1
SCHEMBL13508036 0.85 CA12 (0.39) S1PR5S1PR4PIM1MCL1ACMSD
SCHEMBL19628165 0.85 GPR84 (0.34) S1PR5S1PR4LIMK1GSTP1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) 2019-10-08 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device OR10J3, OCIAD2, OCIAD1 S1PR5 4820/4885S1PR4 4615/4885PIM1 1910/4885
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 4820/4885S1PR4 4615/4885PIM1 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.